CDX2 Mouse Monoclonal Antibody [Clone ID: OTI1A3]

CAT#: TA500251S

Anti-CDX2 mouse monoclonal antibody, clone OTI1A3 (formerly 1A3)

Size: 30 ul 100 ul



  View other "OTI1A3" antibodies (4)

Need it in bulk or conjugated?
Get a free quote

【特别福利】购一抗正装产品(≥50ul或≥50ug),免费领10ul抗体试用装

CNY 800.00


货期*
现货

规格
    • 30 ul

Cited in 1 publication.

Product images

经常一起买 (2)
beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
    • 30 ul

CNY 300.00
CNY 1,430.00


Transient overexpression lysate of caudal type homeobox 2 (CDX2)
    • 100 ug

CNY 3,080.00

Specifications

Product Data
Clone Name OTI1A3
Applications IF, WB
Recommend Dilution WB 1:1000
Reactivity Human, Dog, Mouse, Rat
Host Mouse
Clonality Monoclonal
Immunogen Recombinant protein expressed in E.coli corresponding to amino acids 1-313 of human CDX2
Formulation PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
Concentration 1 mg/ml
Purification Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
Conjugation Unconjugated
Storage Condition Store at -20°C as received.
Predicted Protein Size 33.5 kDa
Gene Name caudal type homeobox 2
Background The level and beta-cell specificity of insulin gene expression are regulated by a set of nuclear proteins that bind to specific sequences within the promoter of the insulin gene (INS; MIM 176730)and interact with RNA polymerase to activate or repress transcription. The proteins LMX1 (MIM600298) and CDX3 are homeodomain proteins that bind an A/T-rich sequence in the insulin promoter and stimulate its transcription.
Synonyms CDX-3; CDX2/AS; CDX3
Reference Data
Protein Families Adult stem cells, Druggable Genome, Embryonic stem cells, ES Cell Differentiation/IPS, Transcription Factors
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Citations (1)

Other Versions

Customer Reviews 
Loading...